[HTML][HTML] Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives

Y Rolland, S Czerwinski, GA Van Kan, JE Morley… - The Journal of nutrition …, 2008 - Elsevier
Sarcopenia is a loss of muscle protein mass and loss of muscle function. It occurs with
increasing age, being a major component in the development of frailty. Current knowledge …

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

JF Rahier, S Ben-Horin, Y Chowers… - Journal of Crohn's …, 2009 - academic.oup.com
The treatment of inflammatory bowel disease (IBD) has been revolutionised over the past
decade by the increasing use of immunomodulators, mainly azathioprine (AZA)/6 …

2018 update of the APLAR recommendations for treatment of rheumatoid arthritis

CS Lau, F Chia, L Dans, A Harrison… - … journal of rheumatic …, 2019 - Wiley Online Library
Aim To update recommendations based on current best evidence concerning the treatment
of rheumatoid arthritis (RA), focusing particularly on the role of targeted therapies, to inform …

managing the adverse events caused by anti‐TNF therapy in inflammatory bowel disease

UN Shivaji, CL Sharratt, T Thomas… - Alimentary …, 2019 - Wiley Online Library
Background Biological therapy is currently widely used to treat IBD. Infliximab, adalimumab
and golimumab are currently licensed anti‐TNF therapies. Biosimilar anti‐TNF monoclonal …

Consensus guidelines for the management of plaque psoriasis

S Hsu, KA Papp, MG Lebwohl, J Bagel… - Archives of …, 2012 - jamanetwork.com
The Canadian Guidelines for the Management of Plaque Psoriasis were reviewed by the
entire National Psoriasis Foundation Medical Board and updated to include newly approved …

BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies

T Ding, J Ledingham, R Luqmani, S Westlake… - …, 2010 - academic.oup.com
Tina Ding1, Jo Ledingham2, Raashid Luqmani3, Sarah Westlake4, Kimme Hyrich5, Mark
Lunt5, Patrick Kiely6, Marwan Bukhari7, Rikki Abernethy8, Ailsa Bosworth9, Andrew …

Targeting TNF and TNF receptor pathway in HIV-1 infection: from immune activation to viral reservoirs

S Pasquereau, A Kumar, G Herbein - Viruses, 2017 - mdpi.com
Several cellular functions such as apoptosis, cellular proliferation, inflammation, and
immune regulation involve the tumor necrosis factor-α (TNF)/TNF receptor (TNFR) pathway …

British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005

CH Smith, AV Anstey, J Barker… - British Journal of …, 2005 - academic.oup.com
Background Psoriasis is a common, persistent, relapsing inflammatory skin disease that can
be associated with significant morbidity. Quality of life studies in psoriasis reveal a negative …

Problems encountered during anti-tumour necrosis factor therapy

SB Desai, DE Furst - Best practice & research Clinical rheumatology, 2006 - Elsevier
Worldwide, over 400 000 patients have been treated with tumour necrosis factor (TNF)-α
antagonists for indications that include rheumatoid arthritis, juvenile rheumatoid arthritis …

Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies

LH Calabrese, NN Zein, D Vassilopoulos - Annals of the rheumatic …, 2006 - ard.bmj.com
Understanding of the natural history and basic biology of hepatitis B virus (HBV) has
increased greatly in recent years. In view of this, the following are reviewed here:(a) recent …